Effectiveness of palivizumab immunoprophylaxis in preterm infants against respiratory syncytial virus disease in Qatar

OBJECTIVE: The primary objective of this study was to document the hospitalization rate due to respiratory syncytial virus (RSV) and compliance with palivizumab use in preterm infants receiving palivizumab immunoprophylaxis during 2009–2012 RSV seasons. DESIGN: This is a descriptive single-center co...

Descripción completa

Detalles Bibliográficos
Autores principales: Abushahin, Ahmad, Janahi, Ibrahim, Tuffaha, Amjad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797460/
https://www.ncbi.nlm.nih.gov/pubmed/29430194
http://dx.doi.org/10.2147/IJGM.S156078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797460/
https://www.ncbi.nlm.nih.gov/pubmed/29430194
http://dx.doi.org/10.2147/IJGM.S156078

Ejemplares similares